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Abstract
Background: Kawasaki disease (KD) is an illness of unknown etiology that mostly occurs in children under 5 years
of age and is the leading cause of acquired heart disease all over the world. Mycoplasma pneumoniae (MP) was one
of the likely causative agents of KD. However, the etiologic effect of MP in KD has not been fully recognized.
Methods: We prospectively analyzed the clinical records of 450 patients with KD hospitalized in Children’s Hospital
of Soochow University from 2012 to 2014. Using medical records, we retrospectively identified patients with low
respiratory tract infection (non-KD group).
Results: Of the 450 KD patients, MP was positive in 62 (13.8 %). The median age of the MP + KD+ group was significantly
older than the MP-KD+ group (25 vs 14.5 months, P < 0.01). MP + KD+ group had higher levels of ESR, N% and CRP than
the MP-KD+ group. MP + KD+ group were more frequent in respiratory disorders than MP-KD+ group with a P < 0.05.
No statistical difference of non-responders or coronary artery lesion was found between the groups.
Conclusions: MP infections are found in an important proportion of the KD patients (13.8 % in our series). MP infection
tended to occur in older populations and with a higher rate of respiratory tract involvement in patients with KD.
No statistical difference of non-responders or coronary artery lesion was found between the MP+ and MP- KD patients.
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Abbreviations: KD, Kawasaki disease; MP, Mycoplasma pneumonia; CAL, Coronary artery lesion; WBC, White blood cell;
PLT, Platelet; N%, neutrophils proportion; CRP, c-reaction protein; ESR, Erythrocyte sedimentation rate; IVIG, Intravenous
immunoglobulin; LRTI, Low respiratory tract infections
Background
Kawasaki disease (KD) is a self-limited vasculitis charac-
terized by fever ≥5 days, conjunctive injection, changes
in extremities, oral mucosal changes, rash, and cervical
lymphadenopathy. The main complication of the febrile
disease is coronary artery lesion (CAL), which makes the
disease the major cause of acquired heart disease in de-
veloped countries [1]. The etiology of KD remains un-
known though nearly fifty years have passed since the
first report of the disease in 1967 [2]. Infection is consid-
ered to be one of the predisposing factors [3–5]. But
despite numbers of investigations and multiple candi-
dates, no unique infectious agent has been identified as
the sole etiologic agent responsible for KD so far.
There are a few KD cases reported to be associated
with the etiologic agent of Mycoplasma pneumoniae
(MP) [6–8], but no systemic study on MP infected (MP+)
KD patients was carried out so far. Thus the etiologic ef-
fect of MP in KD is of particular interest.
The present study was designed to determine the clin-
ical and epidemiological characteristics and CAL in MP+
KD patients and to reveal the differences between the
MP+ and non-MP infected (MP-) KD patients.
Methods
Study patients
We conducted a prospective study in Children’s Hos-
pital of Soochow University during January 1st, 2012
and December 31th, 2014. A standardized protocol was
used to enroll a target number of consecutive patients
from the inpatient ward of cardiology. Patients with a
diagnosis of KD were eligible for inclusion. On
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admission, after obtaining informed consent from the
parents, clinical-epidemiological information was col-
lected by pediatricians. Using medical records, we
retrospectively identified patients with low respiratory
tract infection (LRTI) (non-KD group) from the ward
of pulmonology. All experiments were performed
following the relevant guidelines and regulations of
Soochow University. The study was approved by the
Medical Ethics Committee of Soochow University.
Data collection
Data such as age, sex, season onset, fever duration before
diagnosis, length of stay in hospital, KD-related clinical
manifestations and other systemic involvements, white
blood cell (WBC) count, platelet (PLT), neutrophils pro-
portion (N%), c-reaction protein (CRP), erythrocyte sedi-
mentation rate (ESR), MP antibody, MP-DNA by PCR
and echocardiographic findings within 1 month of onset
were collected and further analyzed. WBC, PLT, N%, CRP
and ESR were tested within 24 h after admission.
MP-DNA detection and evaluation
Nasopharyngeal secretions were collected from each
study participant within 24 h after admission by a lab
technician as previously described [9]. Briefly, an aseptic
plastic sputum catheter was inserted into the nostril to a
depth of about 7–8 cm until reaching the pharynx. Ap-
proximately 2 ml of nasopharyngeal secretions was col-
lected by applying negative pressure. The sample was
mixed with 4–8 ml PBS, and centrifuged for 10 min at
300–500 rpm. The supernatant was discarded and the
pellet was mixed with 4–8 ml PBS and centrifuged for
an additional 10 min. The pellet was stored at 280uC
until testing began.
DNA lysate (Shanghai Shenyou biotechnology company,
Shanghai, China) was added to the sputum pellet follow-
ing washing with PBS. The sample was heated to at 95 °C
for 10 min, centrifuged for 5 min at 12 000 rpm, and then
the supernatant was collected. After extracting the DNA
from the sputum specimen, MP DNA was detected by
fluorescent real-time PCR (BIO-RAD iCycler, USA). The
cyclic temperature settings were 93 °C, 2 min; 93 °C, 45 s;
55 °C, 60 s→ 10 cycles; 93 °C 30 s→ 55 °C, 45 s→
30 cycles. The fluorescence collection point was set at
the 55 °C, 45 s. Ct value was used to quantify the fluor-
escence quantitative PCR results. The following primers
were used: The probe binding sequence was located
between the upstream and downstream primer. The
fluorescent reporter dye at the 59 end of probe was 6-
carboxyfluorescein, and the quencher at the 39 end of
the probe was 6-carboxytetramethylrhodamine. The
primers and probe were purchased from Guangzhou
Daan Gene Ltd. (Guangzhou, China). An MP-negative
sample was defined as having an amplification curve
that was not S-shaped or a Ct value = 30. Both results
indicated that the MP DNA content was below the de-
tection limit. A positive MP sample was defined as hav-
ing an amplification curve that was S-shaped and a Ct
value <30.
Serological analysis for MP
Paired serum samples were collected on admission and at
least 1 week later. IgM antibodies were measured using
the Serion Elisa Mycoplasma pneumoniae IgM kit (Insti-
tut Virion/serion GmbH, Würzburg, Germany) with the
test cut-off 0.5 × mean optical density value of the kit
control serum, as indicated in the insert. The assay was
considered positive if IgM ≥1.1U/ml according to
manufacturer instructions.
Diagnosis of MP infection
Diagnosis of MP infection was based on serology and
PCR findings. Both the presence of IgM antibodies and
positive PCR results were used as sufficient criteria for
current MP infection.
Definition of KD
KD was defined by the presence of ≥5 days of fever and
≥4 of the 5 principal clinical features for KD according
to American Heart Association [1]. These clinical fea-
tures included (1) bilateral non-exudative conjunctival
injection; (2) oral mucosal changes, such as erythema of
the lips or strawberry tongue; (3) changes in extremities,
such as edema, erythema and desquamation; (4) poly-
morphous rash and (5) cervical lymphadenopathy of
≥1.5 cm. Patients with only two or three principal clin-
ical features of KD, in addition to fever, are considered
to have incomplete KD when CAL was confirmed. CAL
(in echocardiography) was defined as an internal lumen
diameter ≥3 mm in children <5 years of age or ≥4 mm in
children >5 years of age. Coronary artery aneurysm (CAA)
was defined as a segmental internal diameter of any
segment ≥1.5 times greater than that of an adjacent seg-
ment. Giant coronary aneurysm was referred to a segmen-
tal internal diameter ≥8 mm [10]. Non-responders were
referred to persistent or recrudescent fever ≥36 h after the
initial IVIG infusion.
Statistical analysis
We used n (%) for categorical variables and median (quar-
tiles) for continuous variables with non-normal distribu-
tion or mean and standard deviation (SD) for those with
normal distribution. We assessed differences in categorical
variables with the χ2 test. We calculated 95 % confidence
interval (95 % CI) for differences in medians with an exact
test. Logistic regression analysis was performed to identify
different clinical characteristics and laboratory parameters
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associated with MP infection. SPSS (version 22.0) software
was used for all statistical analysis.
Results
Clinical features and laboratory parameters of the
patient groups
A total of 483 patients were diagnosed with KD. Thirty-
three patients were excluded because of incomplete data.
The remaining 450 patients were enrolled in this study.
The age of onset ranged from 2 to 129 months with a
median of 17 months old. The male to female ratio was
1.86:1. KD criteria of diagnosis included fever in 100 %
of the patients, rash in 76.2 %, conjunctival injection in
84.2 %, changes in extremities in 77.6 %, cervical lymph-
adenopathy in 61.1 % and mucosal changes in 88 %.
Of the 450 KD patients, MP was positive in 62 (13.8 %)
patients. The MP +KD+ group consisted 62 cases while
the MP-KD+ group consisted 388 cases. The clinical fea-
tures and laboratory parameters of the two groups are
shown in Table 1. The median age of the MP + KD+ group
was significantly older than the MP-KD+ group (25 vs
14.5 months, P < 0.01). MP + KD+ group had higher levels
of ESR, N% and CRP than the MP-KD+ group with sig-
nificant differences after logistic regression analysis.
A total of 6354 patients were included in the non-KD
group. MP was positive in 1302 (20.5 %) patients. The
median age of the 1302 children were 35 months. The
ratio of male to female was 1.46:1. The median age of
patients with MP infection in KD group were significant
younger than that in non-KD group (25 vs 35 months,
P < 0.001). The clinical features and laboratory parame-
ters between the two groups are shown in Table 2.
Epidemiology of MP infection in KD and non-KD patients
The MP infection rate in KD patients increased with
their age, with a statistical significance for age distribu-
tion (P < 0.001). Fewer children younger than 1 year old
had MP infection (1.3 %) than those older than 5 years
old (28 %) (P < 0.001) (Fig. 1a), indicating that the older
children with KD were more prone to MP infection. The
age distribution of MP infection in KD group was simi-
lar to that in non-KD group (Fig. 1b).
The seasons in the Suzhou area of China were defined as
spring (March–May), summer (June–August), autumn
(September–November), and winter (December–February).
During the 3-year period, seasonal discrepancy of MP in-
fection was observed in non-KD group. MP was detected
throughout the year with an epidemic peak observed each
year in summer season. In KD group, the highest propor-
tion of KD onset occurred during March through July
(53 %), with a peak in May. However, seasonal discrepancy
of MP infection was not observed in KD patients (Fig. 2).
Response to treatment in KD patients
A total dose of 2 g/kg of intravenous immunoglobulin
(IVIG) was administered in patients in 432 patients,
mainly during the 5th and 9th day of the disease onset
(98.5 %). Among the patients who did not received IVIG
(initial missed diagnosis and low level of IgA), 7 belonged
to the MP + KD+ group and 11 belonged to the MP-KD+
group. An additional high dose of aspirin of 30–50 mg/kg
was used during the febrile period and thereafter a low
dose of 3–5 mg/kg was administrated until afebrile for
3 days. Non-responders were administered a second dose
of 2 g/kg of IVIG. Intravenous pulse methylprednisolone
Table 1 Clinical features and laboratory parameters of children with Kawasaki disease with or without Mycoplasma pneumoniae
infection
MP + KD+ Group MP-KD+ Group P value
No. of patients (%) 62 (13.7) 388 (86.3) -
Median age (quartiles), m 25 (17, 48) 14.5 (8, 29) <0.01*
Male to female ratio 1.82 1.91 0.62
Median fever duration before the diagnosis of KD (quartiles), days 7 (5, 8) 6 (5, 7) 0.14*
Rash, n (%) 49 (79.0) 294 (75.8) 0.57
Conjunctival injection, n (%) 50 (80.6) 323 (83.2) 0.61
Changes in extremities, n (%) 51 (82.3) 298 (76.8) 0.34
Cervical lymphadenopathy, n (%) 43 (69.4) 233 (60.1) 0.16
Mucosal changes, n (%) 55 (88.7) 340 (87.6) 0.81
ESR, mm/h 39.9 ± 25.4 35.4 ± 24.0 0.03*
WBC, ×109/L 14.6 ± 6.4 14.1 ± 5.0 0.45
PLT, ×109/L 369.8 ± 130.1 381.5 ± 125.4 0.30
N% 68.6 ± 13.8 64.0 ± 15.9 <0.01*
CRP, mg/L 70.6 ± 15.6 64.7 ± 15.1 <0.01*
*Median age, median fever duration before the diagnosis of KD,ESR, N% and CRP were tested by logistic regression analysis to exclude the
interaction betweenparameters
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was administered in 15 (71.4 %) of the non-responders
with a regimen of 2 mg/kg/d for 3 to 5 days. Overall, 411
(95.2 %) patients responded to the initial IVIG treatment
and all non-responders (21 patients, 4.8 %) responded to
the second IVIG treatment with or without methylpred-
nisolone. Of the 21 non-responders, 3 (4.8 %) were MP+
and 18 (4.6 %) were MP- patients. No statistical difference
of non-responders was found between the groups (OR:
1.314, 95 % CI: 0.553–3.236). Intravenous pulse or oral
azithromycin of 10 mg/kg/d for consecutive 3–5 days was
administered in 20 of the MP+ patients with obvious re-
spiratory tract signs and symptoms.
Length of hospitalization and coronary artery lesion in
KD patients
We compared length of hospitalization of the MP+ and
MP- KD patients. 92.1 % of the patients discharged
within 15 days of hospitalization. No significant differ-
ence was found in the length of the hospitalization be-
tween the MP+ and MP- KD patients. Besides, no
significant difference was found in the length of
hospitalization in the patients with azithromycin and
without azithromycin treatment (10 [9, 12], 10 [8, 12],
respectively, P > 0.05).
CAL was found in 108 (24 %) of the patients, most of
whose abnormalities was dilation only (88.0 %). No dif-
ference was found of CAL between the two groups.
These findings are shown in Table 3.
Other systemic involvement in KD patients
Many patients in KD presented with other systemic in-
volvements besides CAL. These results are seen in
Table 4. Respiratory and gastrointestinal disorders were
most commonly seen in both groups (48.21 % and
37.97 %, respectively). Respiratory disorders mainly in-
cluded rhinorrhea, sore throat, cough, sputum and
wheeze. Gastrointestinal disorders mainly included an-
orexia, vomiting, diarrhea and abdominal pain. Urinary
system involvement included urethritis and meatitis.
MP + KD+ group were more frequent in respiratory dis-
orders than MP-KD+ group with a P < 0.05. On the
other hand, there was no difference in the rate of gastro-
intestinal tract, urinary system involvement, aseptic
meningitis and hepatic dysfunction. Besides, other com-
plications like paroditis, arthritis, myocarditis and
arrhythmia were seen in few cases.
Discussion
The etiology of KD remains unclear up to now despite
numbers of studies. Many case reports have found that
infectious agents might play an important role [8, 11–
15]. The mechanism of infectious agents associated with
KD has not been fully understood. Abe et al. [16] sug-
gested that the process of superantigens activating T cell
might be important in the pathophysiology of KD. An-
other species of the Mycoplasma genome, Mycoplasma
arthritidis, has been shown to produce a superantigen
suggesting the possibility that other Mycoplasma species,
like MP, may do likewise [17]. MP was one of the most
reported organisms to cause KD [7, 8], but the clinical
characteristics of MP infected KD have not been thor-
oughly examined. As far as we know, this is by far the
largest study to determine the role of MP infection in
KD.
In our study, MP + KD+ patients were much older
than MP-KD+ patients which was in accordance with
Lee MNet al. [8]. In their research, they found that the
MP group was significantly older than the non-MP
group in KD patients (5.5 ± 3.5 vs 2.8 ± 2.2 years). In our
study, we also compared the median age of patients with
MP infection in KD and non-KD groups. Patients with
Table 2 Clinical features and laboratory parameters of MP
infection children with KD and non-KD disease
KD (n = 62) Non-KD (n = 1302) P
Median age (quartiles), m 25 (17,48) 35 (10,56) <0.01
Male to female ratio 1.82 1.46 0.44
Median length of stay in
hospital (quartiles), days
10 (8, 12) 7 (5–10) <0.01
WBC, ×109/L 14.6 ± 6.4 7.7 ± 4.3 <0.01
PLT, ×109/L 369.8 ± 130.0 274.0 ± 101.0 <0.01
N% 68.6 ± 13.8 51.1 ± 12.3 <0.01
CRP, mg/L 70.6 ± 15.6 22.6 ± 20.8 <0.01
Fig. 1 Age distribution of MP infection in KD (a) and non-KD (b) patients
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MP infection in KD were significantly younger than
those in non-KD group (25 vs 35 months, P < 0.001), al-
though the age distribution of patients with MP is simi-
lar between KD and non-KD group.
Seasonal peaks of MP infection in LRTI has been re-
ported in our previous studies. Outbreaks began in sum-
mer months and peaked during August and September
in Suzhou [9, 18]. The seasonal distribution in our non-
KD group is in line with our previous studies. However,
interestingly, no seasonal peaks of MP infection in KD
was observed in our study. This phenomenon imply that
outbreaks of MP infection in LRTI may not increase the
incidence of MP associated KD.
There was no significant difference in the incidence of
CAL in our study. Lee et al. and his colleagues also
found no difference of both left and right coronary ar-
tery in MP+ and MP- KD patients by analyzing 12 KD
patients and 42 controls [8]. Though MP as an import-
ant causative agent that mainly resides in the respiratory
tract, it may disseminate systemically to the peripheral
blood mononuclear cells and localize in arteries where it
may infect endothelial cells, vascular smooth muscle
cells and monocytes/macrophages, leading to vascular
changes. In earlier years Momiyama Y et al. proposed an
elevated level of MP antiboby was associated with cor-
onary artery disease [19], suggesting a closed relation-
ship between MP and vascular changes. Unfortunately,
there was no difference of CAL or CAA between MP+
and MP- KD patients in our study. But it need to be
verified by larger study samples.
KD itself can lead to respiratory, gastrointestinal, urin-
ary, hepatic and nervous systems disorder [1]. In our
study, we found that respiratory involvement was more
common in MP + KD+ group compared with MP-KD+
group. Respiratory involvement in KD might be a conse-
quence of vessel inflammation with increased vascular
permeability and perivascular edematous changes [20]. It
is confirmed that MP infections involve both the upper
and lower respiratory tract, which could partly explain
why respiratory tract involvement was observed fre-
quently in the MP + KD+ patients. Besides, MP is also
reported to be responsible for non-respiratory tract
manifestations, including neurological, hepatic and car-
diac diseases [21–23]. However, there was no statistical
difference in terms of non-respiratory manifestations be-
tween MP+ and MP- KD patients. This might indicate
that MP plays a minor role in these systems in KD
patients.
In MP infection, it is difficult to set up criteria for the
“gold standard” to detect acute infections. Cultural isola-
tion is 100 % specific but too slow to be of timely diag-
nostic value. There is no universally agreed upon gold
standard serological assay for detection of antibodies to
MP. Paired serology (≥4-fold rise in IgG titer by comple-
ment fixation tests) remains the mainstay for diagnosing
MP [24]. However, our patients were treated with high-
dose IVIG that contain substantial amounts of MP anti-
body. Such passive immunization would greatly increase
MP-IgG. Based on this, in our study we detect MP-IgM,
instead of IgG, to diagnose MP infection. On the other
hand, specific IgM antibody could persist for up to a
year after infection in some patients, but the pathogen is
detected less frequently during the later stages of the
disease. In our study, both the presence of IgM anti-
bodies and positive PCR results were used as sufficient
criteria of current MP infection. So we believed that our
definition of MP infection has great accuracy in deter-
mining MP infection in KD patients.
There are some limitations in the present study. First,
the size of the study population was relatively small.
Therefore, more studies are needed in order to firmly es-
tablish the relationship between simple MP infection
and KD. In addition, overdiagnosis and underdiagnosis
Fig. 2 Seasonal distribution of MP infection in KD and non-KD patients
Table 3 Coronary artery lesions and length of hospitalization in Kawasaki disease patients with or without Mycoplasma pneumoniae
infection
Total (n = 450) MP + KD+ group (n = 62) MP-KD+ group (n = 388) P value
CAL total, n (%) 108 (24.0) 15 (24.2) 93 (24.0) 0.97
Dilation only, n (%) 95 (21.1) 12 (19.4) 83 (21.4) 0.13
Aneurysm (≥4 mm), n (%) 18 (4.0) 3 (4.8) 15 (3.9) 0.72
Giant aneurysm (≥8 mm), n (%) 1 of 18 0 of 3 1 of 15 1.00
Median length of stay in hospital (quartiles), days 10 (8, 12) 10 (8, 12) 10 (8, 12) 0.65
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may exist for the lack of golden diagnostic criteria for
KD and the similarity between MP infection and KD.
Conclusion
We demonstrated 13.8 % patients had MP infection at
the time of KD diagnosis. KD patients with MP infection
tended to occur in older populations and with a higher
rate of respiratory tract involvement. No statistical dif-
ference of non-responders or coronary artery lesion was
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